MM is characterized by widespread disease at diagnosis with the presence of multiple lytic lesions and disseminated involvement of the bone marrow (BM), implying that the progression of MM involves a continuous circulation of the MM cells in the peripheral blood and re-entrance into the BM. Chemokines play a central role in lymphocyte trafficking and homing, specifically the chemokine SDF-1, and its receptors, CXCR4 along with the recently identified receptor CXCR7. We hypothesize that modulation of the capacity of MM cells to reside in their microenvironment will change their biologic properties and induce sensitivity to apoptosis.
Specific Aim 1 : To identify mechanisms of homing of MM cells in response to the SDF-1/CXCR4 axis. We will test this aim by determining the long-term biological sequelae of inhibition of SDF-1-dependent homing of MM and its effect on tumor progression, determining the differences in kinetics of homing between MM cells and other BM microenvironment cells, identifying the downstream signaling pathways that regulate MM cells'homing in response to CXCR4 and CXCR7 in vitro and in vivo, and difference in signaling of these two receptors in MM, and identifying the role of other chemokine receptors and adhesion molecules in the regulation of homing.
Specific Aim 2 : To determine the in vitro and in vivo effects of the SDF-1/CXCR4 axis on adhesion and survival of MM cells by identifying the biological changes that occur in MM cells adherent to the BM microenvironment compared to those in the peripheral blood, identifying the interaction of SDF-1/CXCR4 with adhesion molecules namely VLA-4 and LFA-1, and identifying the effect of inhibition of CXCR4/CXCR7 and/or adhesion molecules on growth and survival of MM cells in vivo.
Specific Aim 3 : To identify mechanisms of egression/mobilization of MM cells in response to CXCR4/CXCR7 inhibition by determining the biological sequelae of mobilization of MM cells in response to inhibition of CXCR4, CXCR7, VLA-4 and MMP2/9 inhibitors, determining the difference in kinetics of mobilization of MM cells compared to other bone marrow cells, and determining whether MM cells mobilized out of the BM will be more sensitive to apoptosis by cytotoxic agents compared to malignant cells residing in the BM. Targeting trafficking will lead to a paradigm shift in therapeutic approaches in MM, where we will alter the capacity of MM cells to reside in their protective bone marrow microenvironment by inducing egression and preventing homing and adhesion, leading to increased sensitivity to apoptosis. Relevance to Public Health: The mechanisms of tumor progression in myeloma are not well understood. We will study the role of the chemokine SDF-1 and its receptors in the regulation of entry of myeloma cells into the bone marrow, their adhesion and their exit into the circulation. Targeting this process by mobilizing myeloma cells out of the marrow will lead to a higher sensitivity to killing of the cells with cytotoxic agents.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA125690-05
Application #
8247088
Study Section
Tumor Microenvironment Study Section (TME)
Program Officer
Merritt, William D
Project Start
2008-04-14
Project End
2014-03-30
Budget Start
2012-04-01
Budget End
2014-03-30
Support Year
5
Fiscal Year
2012
Total Cost
$311,124
Indirect Cost
$104,430
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Maiso, Patricia; Huynh, Daisy; Moschetta, Michele et al. (2015) Metabolic signature identifies novel targets for drug resistance in multiple myeloma. Cancer Res 75:2071-82
Weinstock, Mathew; Aljawai, Yosra; Morgan, Elizabeth A et al. (2015) Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation. Br J Haematol 169:851-8
Zhang, Yu; Moschetta, Michele; Huynh, Daisy et al. (2014) Pyk2 promotes tumor progression in multiple myeloma. Blood 124:2675-86
Azab, Abdel Kareem; Sahin, Ilyas; Moschetta, Michele et al. (2014) CXCR7-dependent angiogenic mononuclear cell trafficking regulates tumor progression in multiple myeloma. Blood 124:1905-14
Bianchi, Giada; Ghobrial, Irene M (2014) Team work matters: dual inhibition puts non-hodgkin lymphoma under siege. Clin Cancer Res 20:5863-5
Roccaro, Aldo M; Sacco, Antonio; Purschke, Werner G et al. (2014) SDF-1 inhibition targets the bone marrow niche for cancer therapy. Cell Rep 9:118-28
Agarwal, Amit; Ghobrial, Irene M (2013) The bone marrow microenvironment in Waldenstrom macroglobulinemia. Clin Lymphoma Myeloma Leuk 13:218-21
Liu, Yang; Quang, Phong; Braggio, Esteban et al. (2013) Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma. PLoS One 8:e66982
Agarwal, Amit; Ghobrial, Irene M (2013) Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease. Clin Cancer Res 19:985-94
Roccaro, Aldo M; Sacco, Antonio; Maiso, Patricia et al. (2013) BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest 123:1542-55

Showing the most recent 10 out of 25 publications